Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease.
Yanai H, Adachi H, Hakoshima M, Katsuyama H.
Int J Mol Sci. 2021 Aug 26;22(17):9221. doi: 10.3390/ijms22179221.
The SGLT2 inhibitor dapagliflozin ameliorates renal fibrosis in hyperuricemic nephropathy.
Hu H, Li W, Hao Y, Peng Z, Zou Z, Wei J, Zhou Y, Liang W, Cao Y.
Cell Rep Med. 2024 Aug 20;5(8):101690. doi: 10.1016/j.xcrm.2024.101690.
Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation.
Johnson RJ, Bakris GL, Borghi C, Chonchol MB, Feldman D, Lanaspa MA, Merriman TR, Moe OW, Mount DB, Sanchez Lozada LG, Stahl E, Weiner DE, Chertow GM.
Am J Kidney Dis. 2018 Jun;71(6):851-865. doi: 10.1053/j.ajkd.2017.12.009. Epub 2018 Feb 27.
Uric Acid in Inflammation and the Pathogenesis of Atherosclerosis.
Kimura Y, Tsukui D, Kono H.
Int J Mol Sci. 2021 Nov 17;22(22):12394. doi: 10.3390/ijms222212394.
Hyperuricemia: An Intriguing Connection to Metabolic Syndrome, Diabetes, Kidney Disease, and Hypertension.
Vareldzis R, Perez A, Reisin E.
Curr Hypertens Rep. 2024 Jun;26(6):237-245. doi: 10.1007/s11906-024-01295-3. Epub 2024 Jan 25.
Management of Gout and Hyperuricemia in CKD.
Vargas-Santos AB, Neogi T.
Am J Kidney Dis. 2017 Sep;70(3):422-439. doi: 10.1053/j.ajkd.2017.01.055. Epub 2017 Apr 26.
[Hyperuricemia].
Hisatome I.
No Shinkei Geka. 2024 Nov;52(6):1167-1178. doi: 10.11477/mf.1436205033.
Hyperuricemia in patients with chronic kidney disease: When and what to treat?
Goicoechea M, García-Marina R.
Nefrologia (Engl Ed). 2025 Jun-Jul;45(6):501334. doi: 10.1016/j.nefroe.2025.501334.
Urate-lowering therapy and kidney outcomes in patients with chronic kidney disease and hyperuricemia.
Nie S, Zhou S, Chen R, Li L, Sun Y, Liu J, Jin L, Shao X, Pang M, Su L, Luo F, Xu X, Hou FF.
Signal Transduct Target Ther. 2025 Dec 9;10(1):399. doi: 10.1038/s41392-025-02497-0.
Insights into renal damage in hyperuricemia: Focus on renal protection (Review).
Yang H, Ying J, Zu T, Meng XM, Jin J.
Mol Med Rep. 2025 Mar;31(3):59. doi: 10.3892/mmr.2024.13424. Epub 2024 Dec 24.
